⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
MOLN News
Molecular Partners AG American Depositary Shares
Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1
globenewswire.com
MOLN
Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight
globenewswire.com
KURA
BMY
IPHA
MRK
MNPR
JAZZ
MOLN
LLY
GSK
AGEN
PFE
Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit
globenewswire.com
MOLN
The Inner Circle acknowledges Ilene Fennoy, MD, MPH as a Pinnacle Professional Member Inner Circle of Excellence
prnewswire.com
COLB
SNY
BMY
PFE
MRK
JNJ
ABBV
GILD
AMGN
REGN
BIIB
CRSP
VRTX
MDLZ
KHC
PEP
KO
SBUX
MCD
YUM
CMG
TSLA
NVDA
GOOG
MSFT
AMZN
META
IBM
ORCL
CSCO
ADBE
CRM
INTC
AMD
QCOM
MU
SMCI
ACN
NOW
PANW
SNPS
CDNS
MRVL
LRCX
KLAC
ASML
AMAT
NXPI
ON
INFY
WMT
COST
HD
LOW
TGT
BBY
MGM
LVS
WYNN
MAR
HPE
HPQ
DELL
XRX
GE
BA
LMT
RTX
GD
NOC
CAT
DE
HON
MMM
AXP
V
MA
JPM
BAC
WFC
GS
MS
DIS
CMCSA
NFLX
T
VZ
CHTR
TMUS
XOM
CVX
SHEL
BABA
JD
PDD
NTES
BIDU
IQ
BILI
EDU
RLX
LI
XPEV
NIO
CPT
M
KSS
ROST
TJX
URBN
PVH
RL
AEO
ANF
LULU
UA
NKE
CROX
EAT
SJM
GIS
ADM
IFF
CPB
KDP
MNST
STZ
CCEP
BUD
MOLN
CRBU
EDIT
NTLA
BEAM
ALNY
AZN
BNTX
MRNA
XBIT
RBLX
EXAS
CRWD
FTNT
OKTA
DDOG
SNOW
PLTR
AI
UPST
PYPL
COIN
MARA
CLSK
RIOT
BTBT
MSTR
Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317
globenewswire.com
MOLN
Molecular Partners to hold oral presentations on DLL3-targeting Radio-DARPin candidate MP0712 at multiple upcoming scientific conferences
globenewswire.com
MOLN
Molecular Partners publishes Phase 1 MP0317 data in Nature Cancer demonstrating tumor-localized CD40 activation and tumor microenvironment remodeling
globenewswire.com
MOLN
Molecular Partners presents three posters at AACR 2026, with new preclinical data for first Switch-DARPin T cell engager MP0632 and DLL3 Radio-DARPin MP0712
globenewswire.com
MOLN
Molecular Partners Announces all Board Proposals Approved, Clare Fisher Elected as New Board Member at Annual General Meeting
globenewswire.com
MOLN
Molecular Partners Publishes Invitation to Annual General Meeting 2026 and Proposes Clare Fisher for Election to its Board of Directors
globenewswire.com
MOLN